论文部分内容阅读
[目的]探讨眼睑恶性肿瘤切除术后异体巩膜移植在眼睑重建中的临床疗效。[方法]选择2007年6月～2010年9月期间某院收治的眼睑恶性肿瘤切除术患者58例,随机将患者分为研究组和对照组。两组患者经相关检查和明确诊断均行眼睑恶性肿瘤切除术后,对照组患者行自体唇黏膜移植和邻近皮瓣转移进行眼睑重建,而研究组患者则行异体巩膜移植术进行眼睑重建治疗,并对两组患者的临床疗效等相关指标进行对比分析。[结果]与对照组相比,研究组的治愈率和总有效率均显著提高,术后发生上睑较对侧上睑下垂1～2mm的比率和眼睑有轻度切迹的比率均显著降低,差异均具有统计学意义(P﹤0.05)。[结论]异体巩膜移植对于眼睑恶性肿瘤切除术后患者的眼睑重建具有十分重要的临床治疗价值。
[Objective] To investigate the clinical efficacy of allogeneic scleral transplantation in eyelid reconstruction after eyelid malignant tumor resection. [Method] Fifty-eight patients with eyelid malignancies resected in a hospital from June 2007 to September 2010 were randomly divided into study group and control group. Two groups of patients after the relevant examination and a clear diagnosis of eyelid resection were performed in the control group of patients with autologous lip mucosa transplantation and adjacent flap transfer eyelid reconstruction while the study group was treated with scleral allograft transplantation for eyelid reconstruction, And the two groups of patients with clinical efficacy and other related indicators for comparative analysis. [Results] Compared with the control group, the cure rate and total effective rate of the study group were significantly increased. The ratio of the upper eyelid to the contralateral ptosis of 1 ~ 2 mm and the mild eyelid notch were significantly decreased , The differences were statistically significant (P <0.05). [Conclusion] Allogeneic scleral transplantation has a very important clinical value for eyelid reconstruction in patients with eyelid malignancies.